Diplomat Releases 2014 Satisfaction Survey Results
FLINT, Mich. – May 15, 2015 – The nation’s largest independent specialty pharmacy announces its 2014 patient satisfaction survey results.
Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today the results from its 2014 patient survey. Every year Diplomat engages an independent third-party agency to evaluate the levels of satisfaction, study the customer’s experience and track its service delivery performance over time.
For 2014, Diplomat received a 99 percent satisfaction rate from patients in all four-survey categories:
- Overall satisfaction
- Telephone courtesy
- Helpfulness of pharmacists
- Helpfulness of patient care staff
The survey found that 95 percent of patients would recommend Diplomat to their family, friends and co-workers.
“The results are inspiring,” said Gary Kadlec, Diplomat president. “It’s crucial to keep a finger on the pulse of the patient experience, and look for ways we can do better. Our company is centered around the patient, and it shows in our continued achievement in patient satisfaction.”
To learn more about Diplomat, visit www.diplomat.is.
Diplomat (NYSE: DPLO) serves patients and physicians in all 50 states. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Kali Lucas, Marketing & Public Relations
810.768.9580 | firstname.lastname@example.org
@DiplomatRxWe are #hiring sales consultants for both NYC and Oakland, California! Come check it out. https://t.co/GDqMaItrsZ3 days ago
@gchabitatRT @gchabitat: Do you have what it takes to be a Habitat Olympian? Join us at @DiplomatRx on 5/5 to find out! https://t.co/5eq5y94hv34 days ago
@DiplomatRxDiplomat Will Dispense ZEJULA™ to Treat Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer… https://t.co/MnQRQdLufl5 days ago
@DiplomatRxFar more than an adventure, their trip was dedicated to assisting people living with #hemophilia… https://t.co/kngmnkvjvU1 week ago
@DiplomatRxDiplomat to Release First Quarter 2017 Operating Results and Host Conference Call on Monday, May 8, 2017… https://t.co/h6vJR7823O2 weeks ago